Bilingual day care in Zurich Kinderkrippe Zürich
Kinderbetreuung in Zürich Kinderkrippe Zürich
Kita in Zürich Kinderkrippe Zürich
Kinderkrippe in Zürich Seebach Kinderkrippe Seebach
Academic Journals Database
disseminating
quality controlled scientific knowledge

Unexpected Modulation of Recall B and T Cell Responses after Immunization with Rotavirus-like Particles in the Presence of LT-R192G

Author(s): Fatou Thiam | Cyrille Di Martino | Fabienne Bon | Annie Charpilienne | Claire Cachia | Didier Poncet | John D. Clements | Christelle Basset | Evelyne Kohli

Journal: Toxins ISSN 2072-6651
Volume: 2; Issue: 8; Start page: 2007; Date: 2010;
Original page

Keywords: LT-R192G | Foxp3 | CD25 | regulatory T cells | B lymphocyte | B-1a lymphocyte | mucosal immunization | rotavirus

ABSTRACT
LT-R192G, a mutant of the thermolabile enterotoxin of E. coli, is a potent adjuvant of immunization. Immune responses are generally analyzed at the end of protocols including at least 2 administrations, but rarely after a prime. To investigate this point, we compared B and T cell responses in mice after one and two intrarectal immunizations with 2/6 rotavirus-like particles (2/6-VLP) and LT-R192G. After a boost, we found, an unexpected lower B cell expansion measured by flow cytometry, despite a secondary antibody response. We then analyzed CD4+CD25+Foxp3+ regulatory T cells (Tregs) and CD4+CD25+Foxp3− helper T cells after in vitro (re)stimulation of mesenteric lymph node cells with the antigen (2/6-VLP), the adjuvant (LT-R192G) or both. 2/6-VLP did not activate CD4+CD25+Foxp3− nor Foxp3+ T cells from non-immunized and 2/6-VLP immunized mice, whereas they did activate both subsets from mice immunized with 2/6-VLP in the presence of adjuvant. LT-R192G dramatically decreased CD4+CD25+Foxp3+ T cells from non-immunized and 2/6-VLP immunized mice but not from mice immunized with 2/6-VLP and adjuvant. Moreover, in this case, LT-R192G increased Foxp3 expression on CD4+CD25+Foxp3+ cells, suggesting specific Treg activation during the recall. Finally, when both 2/6-VLP and LT-R192G were used for restimulation, LT-R192G clearly suppressed both 2/6-VLP-specific CD4+CD25+Foxp3− and Foxp3+ T cells. All together, these results suggest that LT-R192G exerts different effects on CD4+CD25+Foxp3+ T cells, depending on a first or a second contact. The unexpected immunomodulation observed during the recall should be considered in designing vaccination protocols.